Emily Gallagher
Affiliations: |
Google:
"Emily Gallagher"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gallagher EJ, LeRoith D. (2020) Hyperinsulinaemia in cancer. Nature Reviews. Cancer |
| Gallagher EJ, Fei K, Feldman SM, et al. (2020) Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Research : Bcr. 22: 40 |
| Leiter A, Carroll E, Brooks DC, et al. (2020) 1672-P: Characterization of Immune Checkpoint Inhibitor–Mediated Hyperglycemia: Beyond Insulin-Dependent Diabetes Diabetes. 69 |
| Senapati P, Kato H, Lee M, et al. (2019) Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer. Epigenetics & Chromatin. 12: 44 |
| Obr AE, Kumar S, Chang YJ, et al. (2018) Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment. Breast Cancer Research : Bcr. 20: 138 |
| Kang C, LeRoith D, Gallagher EJ. (2018) Diabetes, obesity and breast cancer. Endocrinology |
| Shlomai G, Zelenko Z, Antoniou IM, et al. (2017) OP449 inhibits breast cancer growth without adverse metabolic effects. Endocrine-Related Cancer. 24: 519-529 |
| Gallagher EJ, Zelenko Z, Tobin-Hess A, et al. (2017) Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes. Diabetologia |
| Gallagher EJ, Zelenko Z, Tobin-Hess A, et al. (2016) Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes. Diabetologia |
| Gallagher EJ, LeRoith D, Franco R, et al. (2016) Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways. Diabetes/Metabolism Research and Reviews |